0 Yorumlar
0 hisse senetleri
516 Views
0 önizleme
Site içinde arama yapın
Yeni insanlarla keşfedin, yeni bağlantılar oluşturmak ve yeni arkadaşlar edinmek
-
Please log in to like, share and comment!
-
Asia-Pacific AI in Healthcare Market Size to Reach USD 62.7 Billion by 2034 | Rising Adoption of AI-Driven Diagnostics and Personalized Medicine Fuels 23.1% CAGRThe Asia-Pacific Artificial Intelligence Ai In Healthcare market size was valued at USD 8.0 billion in 2025. The market is projected to grow from USD 9.6 billion in 2026 to USD 62.7 billion by 2034, exhibiting a CAGR of 23.1% during the forecast period. Artificial Intelligence Ai In Healthcare refers to the application of machine‑learning algorithms, natural‑language processing,...0 Yorumlar 0 hisse senetleri 598 Views 0 önizleme
-
Personalized Testing and Supplements Market Investment Opportunities and ForecastThe global Personalized Testing & Supplements Market was valued at USD 13.6 billion in 2025 and is projected to grow from USD 15.7 billion in 2026 to USD 46.3 billion by 2033, registering a remarkable CAGR of 16.7% from 2026 to 2033. The market is experiencing rapid expansion as consumers increasingly seek personalized health solutions tailored to their unique genetics,...0 Yorumlar 0 hisse senetleri 41 Views 0 önizleme
-
BioMEMS Market Growing at 10.2% CAGR Through 2034 Driving Digital Health InnovationAccording to a new report from Intel Market Research, the global BioMEMS market was valued at USD 3.2 billion in 2025 and is projected to reach USD 7.8 billion by 2034, growing at a robust CAGR of 10.2 % during the forecast period (2026–2034). This expansion is driven by the rising demand for portable diagnostic platforms, rapid advances in personalized medicine, and heightened...0 Yorumlar 0 hisse senetleri 1K Views 0 önizleme
-
Global Digital Therapeutics Devices Market Growing at 21.0% CAGRAccording to a new report from Intel Market Research, the global Digital Therapeutics Devices market was valued at USD 6.51 billion in 2025 and is projected to grow from USD 7.82 billion in 2026 to USD 35.78 billion by 2034, exhibiting a robust CAGR of 21.0% during the forecast period (2026–2034). This rapid expansion is underpinned by escalating prevalence of chronic illnesses, soaring...0 Yorumlar 0 hisse senetleri 794 Views 0 önizleme